The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: MLB Playoffs, NFL Analytics, NFL Sports Science, NBA Talk

Ep. 171

Show from 10/09/19


In this episode of Wharton Moneyball our hosts talk with ESPN NFL Insider and co-host of ESPN’s daily Fantasy Focus podcast, Field Yates. Are you wondering what mind blowing changes that may occur in fantasy football? Next our hosts talk with the senior data scientist for Pro Football Focus, Eric Eager. They discuss the correlation between time management and win probability.


Guests: Field Yates is an ESPN NFL Insider and co-host of ESPN’s daily Fantasy Focus podcast. He also appears on the weekly Fantasy Football Now pregame show Sunday mornings on ESPN2, 10a-1p ET. Prior to ESPN, he spent two seasons with the Kansas City Chiefs and four years with the New England Patriots.


Follow him on Twitter @FieldYates


For more information, check out https://espnpressroom.com/us/bios/field-yates/


Eric Eager is a senior data scientist for Pro Football Focus, where he analyzes data for all 32 National Football League teams and as well as over 60 college football teams. Before joining PFF in 2018, he was a professor in the Department of Mathematics and Statistics at the University of Wisconsin – La Crosse, where he published over 20 papers in mathematical biology.


Follow him on Twitter @PFF_Eric


Check out his website: https://www.datacamp.com/instructors/ericeager82



More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.